Your browser doesn't support javascript.
loading
Sensitivity of the Social Behavior Observer Checklist to Early Symptoms of Patients With Frontotemporal Dementia.
Toller, Gianina; Cobigo, Yann; Ljubenkov, Peter A; Appleby, Brian S; Dickerson, Bradford C; Domoto-Reilly, Kimiko; Fong, Jamie C; Forsberg, Leah K; Gavrilova, Ralitza H; Ghoshal, Nupur; Heuer, Hilary W; Knopman, David S; Kornak, John; Lapid, Maria I; Litvan, Irene; Lucente, Diane E; Mckenzie, Ian R; McGinnis, Scott M; Miller, Bruce L; Pedraza, Otto; Rojas, Julio C; Staffaroni, Adam M; Wong, Bonnie; Wszolek, Zbigniew K; Boeve, Brad F; Boxer, Adam L; Rosen, Howard J; Rankin, Katherine P.
Afiliação
  • Toller G; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA gianina.toller@kssg.ch.
  • Cobigo Y; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Ljubenkov PA; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Appleby BS; Department of Neurology, Case Western Reserve University, Cleveland, OH, USA.
  • Dickerson BC; Department of Neurology, Frontotemporal Disorders Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Domoto-Reilly K; Department of Neurology, University of Washington, Seattle, WA, USA.
  • Fong JC; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Forsberg LK; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Gavrilova RH; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Ghoshal N; Department of Neurology, Washington University, St. Louis, MO, USA.
  • Heuer HW; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Knopman DS; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Kornak J; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.
  • Lapid MI; Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
  • Litvan I; Feinberg School of Medicine, Department of Neurology, Northwestern University, Chicago, IL, USA.
  • Lucente DE; Department of Neurology, Frontotemporal Disorders Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Mckenzie IR; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • McGinnis SM; Department of Neurology, Frontotemporal Disorders Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Miller BL; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Pedraza O; Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, FL, USA.
  • Rojas JC; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Staffaroni AM; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Wong B; Department of Neurology, Frontotemporal Disorders Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
  • Wszolek ZK; Department of Neurology, Mayo Clinic, Jacksonville, FL, USA.
  • Boeve BF; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
  • Boxer AL; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Rosen HJ; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
  • Rankin KP; Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, CA, USA.
Neurology ; 2022 May 18.
Article em En | MEDLINE | ID: mdl-35584922
BACKGROUND AND OBJECTIVES: Changes in social behavior are common symptoms of frontotemporal lobar degeneration (FTLD) and Alzheimer's disease syndromes. For early identification of individual patients and differential diagnosis, sensitive clinical measures are required that are able to assess patterns of behaviors and detect syndromic differences in both asymptomatic and symptomatic stages. We investigated whether the examiner-based Social Behavior Observer Checklist (SBOCL) is sensitive to early behavior changes and reflects disease severity within and between neurodegenerative syndromes. METHODS: Asymptomatic individuals and neurodegenerative disease patients were selected from the multisite ALLFTD cohort study. In a sample of participants with at least one timepoint of SBOCL data, we investigated whether the Disorganized, Reactive, and Insensitive subscales of the SBOCL change as a function of disease stage within and between these syndromes. In a longitudinal subsample with both SBOCL and neuroimaging data, we examined whether change over time on each subscale corresponds to progressive gray matter atrophy. RESULTS: 1082 FTLD mutation carriers and non-carriers were enrolled (282 asymptomatic, 341 behavioral variant frontotemporal dementia, 114 semantic and 95 non-fluent variant primary progressive aphasia, 137 progressive supranuclear palsy, 113 Alzheimer's clinical syndrome). The Disorganized score increased between asymptomatic to very mild (p=0.016, estimate=-1.10, 95%CI=[-1.99, -0.22]), very mild to mild (p=0.013, -1.17, [-2.08, -0.26]), and mild to moderate/severe (p<0.001, -2.00, [-2.55, -1.45]) disease stages in behavioral variant frontotemporal dementia regardless of mutation status. Asymptomatic GRN pathogenic gene variant carriers showed more Reactive behaviors (preoccupation with time: p=0.001, 1.11, [1.06, 1.16]; self-consciousness: p=0.003, 1.77, [1.52, 2.01]) than asymptomatic non-carriers (1.01, [0.98, 1.03]; 1.31, [1.20, 1.41]). Insensitive score increased to a clinically abnormal level in advanced stages of behavioral variant frontotemporal dementia (p=0.003, -0.73, [-1.18, -0.29]). Higher scores on each subscale corresponded with higher caregiver burden (p<0.001). Greater change over time corresponded to greater fronto-subcortical atrophy in the semantic-appraisal and fronto-parietal intrinsically connected networks. DISCUSSION: The SBOCL is sensitive to early symptoms and reflects disease severity, with some evidence for progression across asymptomatic and symptomatic stages of FTLD syndromes; thus it may hold promise for early measurement and monitoring of behavioral symptoms in clinical practice and treatment trials. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the Social Behavior Observer Checklist is sensitive to early behavioral changes in FTLD pathogenic variants and early symptomatic individuals in a highly educated patient cohort.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article